antisense (Toagosei)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Nameantisense (Toagosei)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionGrowth factor receptors antagonists

TargetsGrowth factor receptors

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesToagosei

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesToagosei

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus

ATC CodeN/A